The chemical class designated as C14orf106 activators encompasses a spectrum of compounds that influence various cellular processes including chromosome segregation, centromere and kinetochore function, and cell cycle progression. The action of these activators is rooted in their ability to modulate the intracellular pathways that C14orf106 is involved in, specifically targeting the spindle assembly checkpoint, the dynamics of microtubule stabilization, and the regulation of kinetochore attachment to microtubules. The molecular mechanisms by which these activators operate include the inhibition or stabilization of microtubule dynamics, the alteration of kinase activity that is pivotal for centromere and kinetochore maintenance, and the modulation of epigenetic markers that dictate the transcriptional landscape of proteins necessary for chromosome segregation.
In detail, C14orf106 activators comprise inhibitors of enzymes such as Aurora kinases and CDKs, which play a crucial role in the phosphorylation processes pivotal to chromosome alignment and segregation. Additionally, they include compounds that disrupt microtubule polymerization, thereby affecting spindle formation and function. The balance of kinase activities and microtubule dynamics is thus altered, which can lead to the activation of the spindle assembly checkpoint and influence the function of C14orf106 in ensuring proper chromosome segregation during mitosis. Moreover, these activators also encapsulate agents that can induce changes in chromatin architecture and histone modification patterns, thereby indirectly influencing the expression and function of C14orf106. The precise modulation of gene expression and protein function by these activators is critical, as it allows for the fine-tuning of the complex events that govern mitotic progression and genomic stability.
SEE ALSO...
Items 11 to 12 of 12 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
AZ 3146 | 1124329-14-1 | sc-361114 sc-361114A | 10 mg 50 mg | $214.00 $887.00 | 7 | |
Mps1 kinase inhibitor, which could activate the spindle assembly checkpoint and influence C14orf106's role in centromere function. | ||||||
Hesperadin | 422513-13-1 | sc-490384 | 10 mg | $304.00 | ||
Aurora B kinase inhibitor that could activate alterations in kinetochore function, impacting C14orf106 activity related to CENP-A deposition. |